Biostate AI has secured strategic research partnerships in the U.S. and India, and a joint venture in China, dramatically expanding the global dataset for their RNA sequencing-based precision medicine solutions.
Biostate AI uses RNA sequencing, a snapshot of gene activity, to build AI models that accurately guide drug development, therapy selection and personalised health predictions.
The company has solidified its leadership in the development of domestic and global precision medicine solutions with the inking of three major collaborations in the U.S., China, and India.
Biostate
